BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cynapsus Therapeutics Researching Ways to Help Parkinson's Patients Increase Control Over Their "Frozen" Bodies


10/8/2013 8:37:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO, Oct. 7, 2013 /PRNewswire/ -- We may all have our challenges, but people with Parkinson's diseasea degenerative disorder of the central nervous systemcould have more than most. According to the Parkinson's Disease Foundation, as many as one million people in the U.S. and four to five million worldwide suffer from Parkinson's, with numbers growing as populations age. The classic signs and symptoms include tremors, stiffness of the limbs, a mask-like face and difficulty walking.

In the later stages of the disease, people may wake up in a rigid or frozen state, movement-impaired and perhaps also unable to speak. This most often occurs when mainstream treatments such as levodopa or enzyme inhibitors enter the bloodstream too slowly, or wear off quickly, or just do not enter the bloodstream sufficiently. Waking up "frozen"a state that necessitates dependence on caregiverscan understandably trigger depression, and indeed depression hits many Parkinson's patients.

Unfortunately, apomorphinethe only FDA-approved rescue therapy (which is also approved in a number of other countries) to treat these frozen episodeshas traditionally only been given by injection. This fact brings with it several disadvantages. The drug needs to be administered up to several times daily, and the injection can result in painful reactions, including irritation and nodules at the injection site, since apomorphine is only stable in a highly acidic formulation, which is irritant to human tissue it comes in contact with.

One innovative company in Toronto, Canada is actively conducting research using a sublingual thin-film strip to address these issues, and is conducting clinical development research to help those who experience these freezing episodes to gain greater control over their bodies. Cynapsus Therapeutics Inc., a specialty pharmaceutical company, is studying a fast-acting oral reformulation of apomorphine, known as APL-130277, that dissolves under the tongue. This new means of delivering the drug is intended for ease of patient use and to avoid the disadvantages that come with the injectable version. Cynapsus is currently conducting a Phase 1 trial for APL-130277.

"You can just imagine how frightening it is to wake up in a rigid state," says Cynapsus Therapeutics President and CEO Anthony Giovinazzo. "We hope APL-130277 will be able to improve the lives of those who experience them."

To learn more about this company's rapidly developing innovations for people with Parkinson's, visit www.cynapsus.ca.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE Cynapsus Therapeutics Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES